UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
UT 西南 NCI 国家临床试验网络主要学术网站 - U10
基本信息
- 批准号:9248972
- 负责人:
- 金额:$ 70万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-09 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAdultAfrican AmericanAmerican Cancer SocietyAmerican College of Radiology Imaging NetworkAmerican College of Surgeons Oncology GroupAmerican Society of Clinical OncologyAreaBasic ScienceBreastCancer CenterChestClinicClinicalClinical ResearchClinical TrialsCollaborationsCountryDepartment chairDisciplineDiseaseEastern Cooperative Oncology GroupEnrollmentEthicsEthnic OriginFacultyFundingGrantGynecologic Oncology GroupHead and neck structureHematologyHemeHispanicsImageInstitutionLeadLeadershipLungMagnetic Resonance ImagingMalignant neoplasm of lungMedical centerMentorsNCI-Designated Cancer CenterNational Clinical Trials NetworkNational Surgical Adjuvant Breast and Bowel ProjectOncology GroupPatientsPhysician ExecutivesPopulationPositioning AttributePositron-Emission TomographyPrincipal InvestigatorPublicationsRadiation OncologyRadiation Therapy Oncology GroupRecording of previous eventsRecruitment ActivityResearchResearch PersonnelRoleServicesSiteSouthwest Oncology GroupTexasTherapeuticTranslatingTranslational ResearchUniversitiescancer diagnosiscareer developmentdrug discoveryethnic diversityethnic minority populationinnovationmedical schoolsmembermetropolitanmultidisciplinaryneuro-oncologyoncologypatient orientedpatient populationprogramspublic health relevancequantitative imagingracial and ethnicracial minoritytranslational scientist
项目摘要
DESCRIPTION (provided by applicant): The University of Texas Southwestern Medical Center (UTSW) has a history of leadership, translational research, and accrual to cooperative group trials. The PI of this grant is Dr. Joan Schiller, chief of the Division of Heme/Oncology and
Deputy Director of the Simmons Cancer Center (SCC), former Chair of ECOG's Thoracic Committee and currently PI of UTSW's main institution ECOG grant. Co-investigators include Dr. Hak Choy, Chair of UTSW's Department of Radiation Oncology, Vice Chair for Disease Sites in RTOG, and former Chair of RTOG's Thoracic Committee; Dr. David Miller, member of the GOG Board of Directors and Chair of the Uterine Corpus Committee; Dr. Marilyn Leitch, member of the Executive Committee of ACOSOG, and Dr. Phil Evans, immediate past president of the American Cancer Society, who was one of the founding members of the ACRIN Breast committee, and served as the principal investigator at UTSW for ACRIN sponsored trials. In 2012, UTSW enrolled 105 patients on adult co-operative group trials. Since 2006, UTSW faculty have investigated or co-investigated 96 co-operative group publications and 85 abstracts, and have chaired, co-chaired, or served as cooperative committee chair on 34 cooperative group trials. UTSW is also a site for the NCI Centers Quantitative imaging Excellence. UTSW is the only academic medical center and medical school in the Dallas/Ft. Worth (DFW) Metroplex, the fourth largest metropolitan area in the country, and is the only NCI designated Cancer Center in north Texas. UTSW also has a strong clinical and transitional research program and drug discovery program; a SPORE in lung cancer; an Advanced Imaging Research Center; and has access to a diverse ethnic and racial population. In the DFW Metroplex, roughly 10.3% of the populations with a cancer diagnosis are Hispanic, and 14.1% are African American; in 2012, 29.6% of SCC patients going on co-operative group clinical studies were of Hispanic ethnicity, and 13.6% were of African American ancestry. The specific aims of the UTSW UIO are to contribute to and promote: (1) The NCTN by enrolling patients with diverse ethnic and racial background on therapeutic and non-therapeutic trials; (2) The scientific direction of the NCTN by bringing the basic, translational, and imaging research conducted at UTSW into hypothesis driven clinical trials. (3) Multidisciplinary efforts and collaboration across multiple disciplinesand multiple cooperative groups; (4) Service in leadership roles by chairing and co-chairing clinical trials and committees, and by participating in NCI activities and initiatives; and (5) The career development of junior faculty.
描述(由申请人提供):德克萨斯大学西南医学中心(UTSW)具有领导,转化研究和合作小组试验的历史。这笔拨款的首席研究员是琼·席勒医生,他是血红素/肿瘤科的主任
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Eric Gerber其他文献
David Eric Gerber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Eric Gerber', 18)}}的其他基金
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
- 批准号:
10630125 - 财政年份:2020
- 资助金额:
$ 70万 - 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
- 批准号:
10418693 - 财政年份:2020
- 资助金额:
$ 70万 - 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
- 批准号:
9921601 - 财政年份:2020
- 资助金额:
$ 70万 - 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
- 批准号:
10376977 - 财政年份:2020
- 资助金额:
$ 70万 - 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
- 批准号:
10189523 - 财政年份:2020
- 资助金额:
$ 70万 - 项目类别:
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
UT 西南 NCI 国家临床试验网络领先学术网站
- 批准号:
10359155 - 财政年份:2019
- 资助金额:
$ 70万 - 项目类别:
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
UT 西南 NCI 国家临床试验网络领先学术网站
- 批准号:
10062108 - 财政年份:2019
- 资助金额:
$ 70万 - 项目类别:
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
UT 西南 NCI 国家临床试验网络领先学术网站
- 批准号:
10581694 - 财政年份:2019
- 资助金额:
$ 70万 - 项目类别:
UT Southwestern NCI National Clinical Trials Network (NCTN) LAPS - Supplemental Funds YR4
UT 西南 NCI 国家临床试验网络 (NCTN) LAPS - 补充资金 YR4
- 批准号:
10733732 - 财政年份:2019
- 资助金额:
$ 70万 - 项目类别:
Evaluating prior cancer exclusion policy to increase lung cancer trial accrual
评估先前的癌症排除政策以增加肺癌试验的应计数量
- 批准号:
9108931 - 财政年份:2015
- 资助金额:
$ 70万 - 项目类别:
相似海外基金
A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
- 批准号:
10509308 - 财政年份:2022
- 资助金额:
$ 70万 - 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
- 批准号:
10680412 - 财政年份:2022
- 资助金额:
$ 70万 - 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
- 批准号:
10535890 - 财政年份:2022
- 资助金额:
$ 70万 - 项目类别:
A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
- 批准号:
10629374 - 财政年份:2022
- 资助金额:
$ 70万 - 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
- 批准号:
10553725 - 财政年份:2021
- 资助金额:
$ 70万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10494191 - 财政年份:2021
- 资助金额:
$ 70万 - 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
- 批准号:
10328955 - 财政年份:2021
- 资助金额:
$ 70万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10437374 - 财政年份:2021
- 资助金额:
$ 70万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10654831 - 财政年份:2021
- 资助金额:
$ 70万 - 项目类别:
Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability
针对农村年轻非裔美国男性的戒烟干预措施的制定、实施和评估:走向可扩展性
- 批准号:
9896786 - 财政年份:2018
- 资助金额:
$ 70万 - 项目类别: